Sign in
4

Changes in Ownership

ARDELYX, INC. Filed Acc 0001628280-25-041339

Chief Patient Officer sold 80,000 shares at $6.12 ($489,680)

  • Chief Patient Officer acquired 50,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Williams Laura A Chief Patient Officer 2025-08-26 Option exercise 10b5-1 +50,000 $0.99 $49,500 446,322 D
Williams Laura A Chief Patient Officer 2025-08-26 Sale 10b5-1 −50,000 $6.12 $306,050 396,322 D
Williams Laura A Chief Patient Officer 2025-08-26 Sale 10b5-1 −30,000 $6.12 $183,630 366,322 D
Derivatives
Williams Laura A Chief Patient Officer 2025-08-26 Option exercise · Stock Option (Right to Buy) 10b5-1 −50,000 112,000 D
Open-market sales · 80,000 sh · avg $6.12 · $489,680
Loading xslF345X05/wk-form4_1756423821.xml…